The stock market has been unpredictable and volatile all year long. All three major U.S. market indexes are in the red, and with economic problems still at the forefront of everyone's minds, no one knows when things will get better.

Amid these issues, some stocks have performed surprisingly well and are likely to continue this trend for the rest of the year. That's the case for AstraZeneca (NASDAQ: AZN) and Incyte (NASDAQ: INCY). Let's see why these two biotechs can continue on their march forward. 

Continue reading

Source Fool.com